<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Intervacc</provider_name><provider_url>https://intervacc.se/en/</provider_url><author_name>patrik</author_name><author_url>https://intervacc.se/en/author/patrik/</author_url><title>Interim report January &#x2013; March 2021</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content"&gt;&lt;a href="https://intervacc.se/en/interim-report-january-march-2021/"&gt;Interim report January &#x2013; March 2021&lt;/a&gt;&lt;/blockquote&gt;
&lt;script type='text/javascript'&gt;
&lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
		/*! This file is auto-generated */
		!function(d,l){"use strict";var e=!1,n=!1;if(l.querySelector)if(d.addEventListener)e=!0;if(d.wp=d.wp||{},!d.wp.receiveEmbedMessage)if(d.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,i,a,s=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=new RegExp("^https?:$","i"),c=0;c&lt;n.length;c++)n[c].style.display="none";for(c=0;c&lt;s.length;c++)if(r=s[c],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3&lt;(a=parseInt(t.value,10)))a=1e3;else if(~~a&lt;200)a=200;r.height=a}if("link"===t.message)if(i=l.createElement("a"),a=l.createElement("a"),i.href=r.getAttribute("src"),a.href=t.value,o.test(a.protocol))if(a.host===i.host)if(l.activeElement===r)d.top.location.href=t.value}}},e)d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),d.addEventListener("load",t,!1);function t(){if(!n){n=!0;for(var e,t,r=-1!==navigator.appVersion.indexOf("MSIE 10"),i=!!navigator.userAgent.match(/Trident.*rv:11\./),a=l.querySelectorAll("iframe.wp-embedded-content"),s=0;s&lt;a.length;s++){if(!(e=a[s]).getAttribute("data-secret"))t=Math.random().toString(36).substr(2,10),e.src+="#?secret="+t,e.setAttribute("data-secret",t);if(r||i)(t=e.cloneNode(!0)).removeAttribute("security"),e.parentNode.replaceChild(t,e)}}}}(window,document);
//--&gt;&lt;!]]&gt;
&lt;/script&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://intervacc.se/en/interim-report-january-march-2021/embed/" width="600" height="338" title="&#x201C;Interim report January &#x2013; March 2021&#x201D; &#x2014; Intervacc" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;</html><description>The period in summary First quarter January 1 &#x2013; March 31, 2021 The regulatory process for the Company&#x2019;s Marketing Authorization Application (MAA) for Strangvac in Europe has proceeded according to plan. On January 12th Intervacc submitted the responses to the Day 120 questions to the European Medicines Agency (EMA). The Company estimates that it is [&hellip;]</description><thumbnail_url>http://intervacc.se/wp-content/uploads/2021/05/Andreas-21_300-150x150.png</thumbnail_url></oembed>
